140 related articles for article (PubMed ID: 7907819)
1. IL-12 holds promise against cancer, glimmer of AIDS hope.
Hall SS
Science; 1994 Mar; 263(5154):1685-6. PubMed ID: 7907819
[No Abstract] [Full Text] [Related]
2. T cell shift: key to AIDS therapy?
Cohen J
Science; 1993 Oct; 262(5131):175-6. PubMed ID: 8211135
[No Abstract] [Full Text] [Related]
3. Interleukins and the immune system 2.
O'Garra A
Lancet; 1989 May; 1(8645):1003-5. PubMed ID: 2565475
[No Abstract] [Full Text] [Related]
4. Glimmer of hope for T cell booster?
Cohen J
Science; 1995 Mar; 267(5202):1261. PubMed ID: 7871417
[No Abstract] [Full Text] [Related]
5. Protection from HIV infection or AIDS?
Miedema F; Meyaard L; Klein MR
Science; 1993 Nov; 262(5136):1074-6. PubMed ID: 8235627
[No Abstract] [Full Text] [Related]
6. IL-12: initiation cytokine for cell-mediated immunity.
Scott P
Science; 1993 Apr; 260(5107):496-7. PubMed ID: 8097337
[No Abstract] [Full Text] [Related]
7. Cytokine patterns during the progression to AIDS.
Mosmann TR
Science; 1994 Jul; 265(5169):193-4. PubMed ID: 8023139
[No Abstract] [Full Text] [Related]
8. (IL-)12 and 21: a new kind of help in the follicles.
Nurieva RI; Dong C
Immunol Cell Biol; 2009; 87(8):577-8. PubMed ID: 19907426
[No Abstract] [Full Text] [Related]
9. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro.
Clerici M; Lucey DR; Berzofsky JA; Pinto LA; Wynn TA; Blatt SP; Dolan MJ; Hendrix CW; Wolf SF; Shearer GM
Science; 1993 Dec; 262(5140):1721-4. PubMed ID: 7903123
[TBL] [Abstract][Full Text] [Related]
10. IL-22 and inflammation: leukin' through a glass onion.
Zenewicz LA; Flavell RA
Eur J Immunol; 2008 Dec; 38(12):3265-8. PubMed ID: 19016525
[TBL] [Abstract][Full Text] [Related]
11. Open clinical trials for HIV/AIDS treatments.
Hanna L
BETA; 1997 Mar; ():52-6. PubMed ID: 11364531
[TBL] [Abstract][Full Text] [Related]
12. [Binding of HIV-1 by "soluble" CD4 receptor--new therapeutic possibilities in AIDS].
Nowak J
Pol Tyg Lek; 1989 Apr; 44(17):401-2. PubMed ID: 2533976
[No Abstract] [Full Text] [Related]
13. Soluble CD4: another therapeutic option in HIV infection.
Lancet; 1990 May; 335(8698):1128-30. PubMed ID: 1971867
[No Abstract] [Full Text] [Related]
14. Immunologic developments in AIDS--1985.
Jacobs JL; Murray HW
Year Immunol; 1986; 2():323-8. PubMed ID: 3033948
[No Abstract] [Full Text] [Related]
15. Stem cells to treat HIV.
Fricker J
Mol Med Today; 1997 May; 3(5):186-7. PubMed ID: 9176877
[No Abstract] [Full Text] [Related]
16. HIV and Tfh Cells: Circulating New Ideas to Identify and Protect.
Chahroudi A; Silvestri G
Immunity; 2016 Jan; 44(1):16-18. PubMed ID: 26789919
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-12 and its role in the generation of TH1 cells.
Trinchieri G
Immunol Today; 1993 Jul; 14(7):335-8. PubMed ID: 8103338
[TBL] [Abstract][Full Text] [Related]
18. A TH1-->TH2 switch is a critical step in the etiology of HIV infection.
Clerici M; Shearer GM
Immunol Today; 1993 Mar; 14(3):107-11. PubMed ID: 8096699
[TBL] [Abstract][Full Text] [Related]
19. Whole-body hyperthermia.
Shecterle LM; St Cyr JA
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):391. PubMed ID: 7552503
[No Abstract] [Full Text] [Related]
20. The treatment of AIDS and cancer in the third millennium.
Gallo RC
Am J Med; 1995 Dec; 99(6A):6S-10S. PubMed ID: 8585540
[No Abstract] [Full Text] [Related]
[Next] [New Search]
